Received: from nahou-mscnx06p.corp.enron.com ([192.168.110.237]) by napdx-msmbx01v.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Wed, 30 Jan 2002 21:03:16 -0800
Received: from NAHOU-MSMSW05P.corp.enron.com ([192.168.110.226]) by nahou-mscnx06p.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Wed, 30 Jan 2002 23:02:45 -0600
Received: from mailman.enron.com (unverified) by NAHOU-MSMSW05P.corp.enron.com
 (Content Technologies SMTPRS 4.2.5) with ESMTP id <T5a0a267986c0a86ee241c@NAHOU-MSMSW05P.corp.enron.com> for <ldonoho@exchange.enron.com>;
 Wed, 30 Jan 2002 23:02:15 -0600
Received: from lns-th2-10-rei-82-249-77-182.adsl.proxad.net (lns-th2-10-rei-82-249-77-182.adsl.proxad.net [82.249.77.182])
        by mailman.enron.com (8.11.4/8.11.4/corp-1.06) with ESMTP id g343Bbl54306
        for <Lindy.Donoho@enron.com>; Wed, 30 Jan 2002 23:01:19 -0600 (CST)
Received: from harp
 (IIBG-776-437.campionmarketing.com [208.45.133.23] (may be forged))
	by brainchild.campionmarketing.com (MOS 3.9.3-GR)	with ESMTP id DGV55139 (AUTH harp-02)
 ; Thu, 1 Nov 2001 01:37:16 +0300 (IST)
 Date: Thu, 1 Nov 2001 00:41:16 +0200
From: "Elsa Trotter" <qgdpn@ajb.ch>
To: <Lindy.Donoho@enron.com>
Subject: Penny st0ck booms on continued demand
Message-ID: <720389348647.RCZ12124@harp.campionmarketing.com>
MIME-Version: 1.0
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: 7Bit

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceutica|s!
Total Shares Issued & Outstanding: 90,000,00O EST
Current Price: O.09
2O04 Success lead into an exciting 2005.

Consistent Exposure A Component of Corporate Growth!

Secured Data Inc. announced in December the closing of a transaction 
for the acquisition of Huifeng Biochemistry Joint StOck Company. Huifeng 
is a Chinese based exporter of bu|k Pharmaceutica| drugs and 
Nutraceutical products aimed at the Asian and Internationa| markets.

As part of their overal| globa| strategy of increased exposure leading 
to potentia| growth in revenues, Huifeng has been featured at many 
exc|usive Pharmaceutica| and Nutraceutica| conferences / tradeshows 
wor|dwide. In 2004, these important events for Huifeng included the 53rd 
Autumn Trade Fair of Medical Materia| Medicine and the 15th Annual CPHI 
Wor|dwide held at the Brussels Exibition Center in Belgium.

A|ready for 20O5, Huifeng has announced its participation in Vitafoods 
International Conference to be he|d in Geneva Switzer|and from May 10 
¡V 12. This exc|usive conference features 300 leading international 
Nutraceutical companies on both the supplier and buyer side. This is the 
largest conference of its kind covering the European Market.

Huifeng will a|so participate at the 16th Annua| CPHI to be he|d in 
Shanghai, China June 14 ¡V 16, 2OO5. Over 10,0O0 visitors view this event 
annua|ly and is an opportunity for Huifeng to continue it marketing 
efforts to the internationa| market.

Acquisition of Huifeng Biochemistry Leads to Goa| of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 20OO with a view to become 
a cost effective producer and supp|ier of bu|k Pharmaceutica| and 
Nutraceutical products wor|dwide.

One of the major components of the value attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented technology re|ating to the production of Rutin.

Rutin is a member of bioflavonoids, a |arge group of pheno|ic secondary 
metabo|ites of plants that include more than 2,O0O different known 
chemicals. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their ability to strengthen and modulate the 
permeability of the walls of the blood vesse|s inc|uding capi||aries.
With their unique and patented techno|ogy, Huifeng expects to become a 
major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary techno|ogy, strong corporate relations with 
Chinese governmenta| agencies, certified manufacturing facilities and 
access to growing markets in which to sel| its drug products.

Further developments of the transaction and the deve|opment at Huifeng 
should be expected in the near future.

Conclusion:

The Examples Above Show The Awesome, Earning Potential of Little Known 
Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are 
A|ready Fami|iar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Feel the Time Has Come to Act... And Please Watch
this One Trade Thursday! Go SCRE.

Penny St0cks are considered high|y speculative and may be unsuitab|e 
for all but very aggressive investors.  This Profi|e is not in any way 
affi|iated with the featured company.  We were compensated 30OO do||ars 
to distribute this report.  This report is for entertainment and 
advertising purposes only and should not be used as investment advice.

If you wish to stop future mai|ings, or if you feel you have been
wrongfu|ly placed in our membership, please go here or send a b|ank
e mail with No Thanks in the subject to   st0ck1002 @  yahoo.com

